Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
eypt
/
EyePoint Pharmaceuticals Inc
EYPT
Add to Watchlist
12.190
USD
-0.280
-2.25%
Close 07-24 16:00(ET)
Quotes delayed by 15 min
USD
0.000
After-hours (ET)
1.01B
Market Cap
Loss
P/E TTM
EyePoint Pharmaceuticals Inc
12.190
-0.280
-2.25%
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Shareholding Stats
Updated: Wed, May 13
Updated: Wed, May 13
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Cormorant Asset Management, LP
9.86%
Suvretta Capital Management, LLC
9.34%
BlackRock Institutional Trust Company, N.A.
6.48%
Franklin Advisers, Inc.
5.89%
Federated Hermes Global Investment Management Corp.
5.74%
Other
62.70%
Shareholders
Shareholders
Proportion
Cormorant Asset Management, LP
9.86%
Suvretta Capital Management, LLC
9.34%
BlackRock Institutional Trust Company, N.A.
6.48%
Franklin Advisers, Inc.
5.89%
Federated Hermes Global Investment Management Corp.
5.74%
Other
62.70%
Shareholder Types
Shareholders
Proportion
Hedge Fund
37.20%
Investment Advisor
29.27%
Investment Advisor/Hedge Fund
29.25%
Private Equity
3.87%
Individual Investor
3.67%
Venture Capital
2.61%
Research Firm
2.18%
Bank and Trust
1.18%
Pension Fund
0.14%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
381
88.53M
105.59%
-2.75M
2025Q4
363
69.86M
126.07%
--
2025Q3
373
69.94M
127.01%
+1.23K
2025Q2
381
69.95M
127.71%
-5.27M
2025Q1
371
75.32M
126.89%
-11.89M
2024Q4
359
75.24M
109.81%
+11.20M
2024Q3
343
59.71M
126.62%
+193.11K
2024Q2
330
60.06M
120.79%
+1.75M
2024Q1
313
56.72M
108.78%
+2.51M
2023Q4
268
50.21M
76.86%
+16.41M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Cormorant Asset Management, LP
8.27M
9.91%
-60.00K
-0.72%
Dec 31, 2025
Suvretta Capital Management, LLC
7.83M
9.38%
+1.63M
+26.40%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
5.43M
6.51%
+1.15M
+26.73%
Dec 31, 2025
Franklin Advisers, Inc.
4.94M
5.92%
+798.84K
+19.31%
Dec 31, 2025
Federated Hermes Global Investment Management Corp.
4.81M
5.77%
+1.23M
+34.41%
Dec 31, 2025
Adage Capital Management, L.P.
4.70M
5.63%
-859.78K
-15.46%
Dec 31, 2025
Paradigm BioCapital Advisors LP
4.19M
5.02%
+500.79K
+13.57%
Feb 17, 2026
TCG Crossover Management, LLC
3.57M
4.28%
--
--
Dec 31, 2025
Janus Henderson Investors
2.94M
3.52%
+2.94M
--
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Virtus LifeSci Biotech Clinical Trials ETF
1%
Simplify Health Care ETF
0.99%
State Street SPDR S&P Pharmaceuticals ETF
0.98%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
0.95%
Invesco Dorsey Wright SmallCap Momentum ETF
0.36%
Federated Hermes MDT Small Cap Core ETF
0.3%
iShares Micro-Cap ETF
0.15%
iShares Health Innovation Active ETF
0.15%
ProShares Ultra Nasdaq Biotechnology
0.12%
Invesco Nasdaq Biotechnology ETF
0.09%
View more
Virtus LifeSci Biotech Clinical Trials ETF
Proportion
1%
Simplify Health Care ETF
Proportion
0.99%
State Street SPDR S&P Pharmaceuticals ETF
Proportion
0.98%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
Proportion
0.95%
Invesco Dorsey Wright SmallCap Momentum ETF
Proportion
0.36%
Federated Hermes MDT Small Cap Core ETF
Proportion
0.3%
iShares Micro-Cap ETF
Proportion
0.15%
iShares Health Innovation Active ETF
Proportion
0.15%
ProShares Ultra Nasdaq Biotechnology
Proportion
0.12%
Invesco Nasdaq Biotechnology ETF
Proportion
0.09%